Disease modification in ankylosing spondylitis
- 1 February 2010
- journal article
- review article
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 6 (2) , 75-81
Abstract
The concept of disease modification in ankylosing spondylitis (AS) incorporates aspects of inflammation, bone destruction and new bone formation. The degree to which inflammation and new bone formation are linked remains conjectural, but data from MRI studies of spinal inflammation support the concept of such coupling; however, these studies also suggest a role for the involvement of noninflammatory pathways, such as those involving bone morphogenetic proteins, wingless proteins and Dickkopf-1, in the formation of new bone. The main clinical outcome that reflects disease modification is the modified Stoke Ankylosing Spondylitis Spine Score, which assesses abnormalities in the anterior vertebral corners of the cervical and lumbar spine. However, radiographic progression can only be reliably detected using this method after at least 2 years, and this delay precludes the conduct of placebo-controlled trials on ethical grounds. Preliminary data using this scoring tool suggest that cyclooxygenase-2-selective NSAIDs might reduce disease progression if used continuously over 2 years. By contrast, three different anti-tumor necrosis factor therapies have shown no impact on radiographic progression. Therapeutic trials recruiting patients early in their disease course and at high risk of radiographic progression constitute a high priority for clinical research in AS.Keywords
This publication has 54 references indexed in Scilit:
- Progress in Spondylarthritis. Mechanisms of new bone formation in spondyloarthritisArthritis Research & Therapy, 2009
- The relationship between inflammation and new bone formation in patients with ankylosing spondylitisArthritis Research & Therapy, 2008
- Human Th17 cellsArthritis Research & Therapy, 2008
- Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variantsNature Genetics, 2007
- Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cellsNature Immunology, 2007
- Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytesAnnals of the Rheumatic Diseases, 2007
- TH-17 cells in the circle of immunity and autoimmunityNature Immunology, 2007
- A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk GenesThe American Journal of Human Genetics, 2007
- Bone morphogenetic proteins in destructive and remodeling arthritisArthritis Research & Therapy, 2007
- Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitisArthritis Care & Research, 2005